US Patent 11267843 Stereodefining L-monomers
All edits
Edits on 13 Dec, 2023
Golden AI
Edits made to:
Article (+437 characters)
Article
Patent abstract
Stereodefined phosphorothioate oligonucleotides, related nucleoside monomers and methods of synthesis of both are described. The disclosed isobutyryl protected L-LNA-G monomers have following Formula 50 or 51 where R3 is independently CH2ODMTr or CH2OMMTr and R8, when present, is cyanoethyl. The monomers have improved solubility and stability characteristics, resulting in improved efficacy in oligonucleotide synthesis.
Edits on 20 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 24 Mar, 2023
Golden AI
Infobox
Is a
Patent Jurisdiction
Patent Number
112678430
Date of Patent
March 8, 2022
0Patent Application Number
160862520
Date Filed
March 2, 2017
0Official Website
Patent Primary Examiner
Edits on 22 Mar, 2023
Golden AI
Infobox
Patent Citations
Edits on 25 Sep, 2022
Golden AI
Infobox
Is a
Patent Jurisdiction
Patent Number
112678430
Date of Patent
March 8, 2022
0Patent Application Number
160862520
Date Filed
March 2, 2017
0Official Website
Patent Primary Examiner
Edits on 6 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 9 Mar, 2022
Golden AI
Edits made to:
Infobox (+9 properties)
US Patent 11267843 Stereodefining L-monomers
Infobox
Is a
Patent jurisdiction
Patent number
11267843
Date of patent
March 8, 2022
Patent application number
16086252
Date Filed
March 2, 2017
Patent primary examiner
Find more entities like US Patent 11267843 Stereodefining L-monomers
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
